These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2999376)

  • 1. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats.
    Rakhit A; Kochak G; Dotson R; Tipnis V
    J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans.
    Rakhit A; Hurley ME; Tipnis V; Coleman J; Rommel A; Brunner HR
    J Clin Pharmacol; 1986 Mar; 26(3):156-64. PubMed ID: 3007583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of renal clearance of furosemide by pentopril, an angiotensin-converting enzyme inhibitor.
    Rakhit A; Kochak GM; Tipnis V; Hurley ME
    Clin Pharmacol Ther; 1987 May; 41(5):580-6. PubMed ID: 3032491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food on the bioavailability of pentopril, an angiotensin-converting-enzyme inhibitor, in healthy subjects.
    Rakhit A; Hurley ME; Redalieu E; Kochak G; Tipnis V; Coleman J; Rommel A
    J Clin Pharmacol; 1985 Sep; 25(6):424-8. PubMed ID: 2997306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renal impairment on disposition of pentopril and its active metabolite.
    Rakhit A; Radensky P; Szerlip HM; Kochak GM; Audet PR; Hurley ME; Feldman GM
    Clin Pharmacol Ther; 1988 Jul; 44(1):39-48. PubMed ID: 3391004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentopril-cimetidine interaction caused by a reduction in hepatic blood flow.
    Kochak GM; Rakhit A; Thompson TN; Hurley ME
    J Clin Pharmacol; 1988 Mar; 28(3):222-7. PubMed ID: 3360970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of RU44403, an active form of newly developed angiotensin-converting enzyme inhibitor (RU44570) in the rat.
    Hirayama M; Kurihara A; Manabe T; Hasegawa Y
    Drug Metab Dispos; 1994; 22(4):601-6. PubMed ID: 7956736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of pentopril in the elderly.
    Rakhit A; Kochak GM; Tipnis V; Radensky P; Hurley ME; Williams R
    Br J Clin Pharmacol; 1987 Sep; 24(3):351-7. PubMed ID: 2822067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of metabolite pharmacokinetics for orally administered prodrugs.
    Kochak GM; Rakhit A
    Drug Metab Dispos; 1987; 15(4):456-9. PubMed ID: 2888616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-chromatographic determination of an angiotensin converting enzyme inhibitor, CGS 13945, and its active metabolite (CGS 13934) in plasma.
    Rakhit A; Tipnis V
    Clin Chem; 1984 Jul; 30(7):1237-9. PubMed ID: 6329555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat.
    Nemes KB; Abermann M; Bojti E; Grézal G; Al-Behaisi S; Klebovich I
    J Pharm Pharmacol; 2000 Jan; 52(1):47-51. PubMed ID: 10716602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and cardiovascular pharmacodynamics of HP 749 (besipirdine HCl) and metabolite P86-7480 in the conscious monkey.
    Hubbard JW; Hsu RS; Griffiths L; Natarajan C; Dean R; Dileo EM; Hintze TH
    J Clin Pharmacol; 1995 Jul; 35(7):688-96. PubMed ID: 7560249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of perindopril and its metabolites in healthy volunteers.
    Devissaguet JP; Ammoury N; Devissaguet M; Perret L
    Fundam Clin Pharmacol; 1990; 4(2):175-89. PubMed ID: 2351367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation studies of di-acid angiotensin converting enzyme inhibitors.
    Drummer OH; Kourtis S
    Arzneimittelforschung; 1987 Nov; 37(11):1225-8. PubMed ID: 2964241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.
    Grislain L; Mocquard MT; Dabe JF; Bertrand M; Luijten W; Marchand B; Resplandy G; Devissaguet M
    Xenobiotica; 1990 Aug; 20(8):787-800. PubMed ID: 2219962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat.
    Caccia S; Cappi M; Fracasso C; Garattini S
    Psychopharmacology (Berl); 1990; 100(4):509-14. PubMed ID: 2320712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.